Cargando…
Striving for optimal bronchodilation: focus on olodaterol
β(2)-agonists were introduced in the 1940s as bronchodilators to be used in obstructive respiratory diseases. Long-acting β(2)-agonists have been a mainstay of bronchodilating treatment for decades. Recently, agents extending their effect to 24 hours and thus allowing the once-daily administration w...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780202/ https://www.ncbi.nlm.nih.gov/pubmed/27042036 http://dx.doi.org/10.2147/COPD.S96070 |